Effect of clindamycin on growth and haemolysin production by Escherichia coli

Nina Boe, E. Patchen Dellinger, B. H. Minshew

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The effect of clindamycin on growth and haemolysin production by four strains of Escherichia coli was tested. Clindamycin MICs were > 256 mg/l for all strains. Clindamycin concentrations of 16-256 mg/l significantly inhibited growth, while concentrations from 2-32 mg/l significantly inhibited haemolysin production. Administration of clindamycin to rats with peritonitis due to haemolytic E. coli reduced mortality. Subinhibitory concentrations of clindamycin can inhibit growth and haemolysin production by E. coli and reduce mortality in an animal model of haemolytic E. coli peritonitis.

Original languageEnglish (US)
Pages (from-to)105-116
Number of pages12
JournalJournal of Antimicrobial Chemotherapy
Volume12
Issue numberSUPPL. C
StatePublished - 1983
Externally publishedYes

Fingerprint

Hemolysin Proteins
Clindamycin
Escherichia coli
Growth
Peritonitis
Mortality
Animal Models

ASJC Scopus subject areas

  • Microbiology
  • Pharmacology

Cite this

Effect of clindamycin on growth and haemolysin production by Escherichia coli. / Boe, Nina; Patchen Dellinger, E.; Minshew, B. H.

In: Journal of Antimicrobial Chemotherapy, Vol. 12, No. SUPPL. C, 1983, p. 105-116.

Research output: Contribution to journalArticle

Boe, N, Patchen Dellinger, E & Minshew, BH 1983, 'Effect of clindamycin on growth and haemolysin production by Escherichia coli', Journal of Antimicrobial Chemotherapy, vol. 12, no. SUPPL. C, pp. 105-116.
Boe, Nina ; Patchen Dellinger, E. ; Minshew, B. H. / Effect of clindamycin on growth and haemolysin production by Escherichia coli. In: Journal of Antimicrobial Chemotherapy. 1983 ; Vol. 12, No. SUPPL. C. pp. 105-116.
@article{fa3a5e5194764a9396195f71d8e82576,
title = "Effect of clindamycin on growth and haemolysin production by Escherichia coli",
abstract = "The effect of clindamycin on growth and haemolysin production by four strains of Escherichia coli was tested. Clindamycin MICs were > 256 mg/l for all strains. Clindamycin concentrations of 16-256 mg/l significantly inhibited growth, while concentrations from 2-32 mg/l significantly inhibited haemolysin production. Administration of clindamycin to rats with peritonitis due to haemolytic E. coli reduced mortality. Subinhibitory concentrations of clindamycin can inhibit growth and haemolysin production by E. coli and reduce mortality in an animal model of haemolytic E. coli peritonitis.",
author = "Nina Boe and {Patchen Dellinger}, E. and Minshew, {B. H.}",
year = "1983",
language = "English (US)",
volume = "12",
pages = "105--116",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "SUPPL. C",

}

TY - JOUR

T1 - Effect of clindamycin on growth and haemolysin production by Escherichia coli

AU - Boe, Nina

AU - Patchen Dellinger, E.

AU - Minshew, B. H.

PY - 1983

Y1 - 1983

N2 - The effect of clindamycin on growth and haemolysin production by four strains of Escherichia coli was tested. Clindamycin MICs were > 256 mg/l for all strains. Clindamycin concentrations of 16-256 mg/l significantly inhibited growth, while concentrations from 2-32 mg/l significantly inhibited haemolysin production. Administration of clindamycin to rats with peritonitis due to haemolytic E. coli reduced mortality. Subinhibitory concentrations of clindamycin can inhibit growth and haemolysin production by E. coli and reduce mortality in an animal model of haemolytic E. coli peritonitis.

AB - The effect of clindamycin on growth and haemolysin production by four strains of Escherichia coli was tested. Clindamycin MICs were > 256 mg/l for all strains. Clindamycin concentrations of 16-256 mg/l significantly inhibited growth, while concentrations from 2-32 mg/l significantly inhibited haemolysin production. Administration of clindamycin to rats with peritonitis due to haemolytic E. coli reduced mortality. Subinhibitory concentrations of clindamycin can inhibit growth and haemolysin production by E. coli and reduce mortality in an animal model of haemolytic E. coli peritonitis.

UR - http://www.scopus.com/inward/record.url?scp=0021079859&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021079859&partnerID=8YFLogxK

M3 - Article

C2 - 6358179

AN - SCOPUS:0021079859

VL - 12

SP - 105

EP - 116

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - SUPPL. C

ER -